Bayesian modeling for the detection of adverse events underreporting in clinical trials
View ORCID ProfileYves Barmaz, View ORCID ProfileTimothé Ménard
doi: https://doi.org/10.1101/2020.12.18.20245068
Yves Barmaz
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PhDTimothé Ménard
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PharmD
- Supplementary Material #2[supplements/245068_file05.pdf]
- Supplementary Material #1[supplements/245068_file06.xls]
Posted May 12, 2021.
Bayesian modeling for the detection of adverse events underreporting in clinical trials
Yves Barmaz, Timothé Ménard
medRxiv 2020.12.18.20245068; doi: https://doi.org/10.1101/2020.12.18.20245068
Subject Area
Subject Areas
- Addiction Medicine (422)
- Allergy and Immunology (746)
- Anesthesia (217)
- Cardiovascular Medicine (3215)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13229)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5052)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3174)
- Health Policy (1126)
- Hematology (421)
- HIV/AIDS (998)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4794)
- Nursing (253)
- Nutrition (712)
- Oncology (2470)
- Ophthalmology (699)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (319)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1274)
- Primary Care Research (548)
- Public and Global Health (7357)
- Radiology and Imaging (1666)
- Respiratory Medicine (965)
- Rheumatology (472)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (229)
- Urology (199)